Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665-Reference-Cited by-同舟云学术

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665

Published:2009-01-01 Issue:1 Volume:99 Page:42-47
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Eisenberg Burton L.,Harris Jonathan,Blanke Charles D.,Demetri George D.,Heinrich Michael C.,Watson James C.,Hoffman John P.,Okuno Scott,Kane John M.,von Mehren Margaret

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference28 articles.

1. Gastric smooth muscle tumors; diagnostic dilemmas and factors affecting outcome;Sanders;World J Surg,1996

2. Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival;Dematteo;Ann Surg,2000

3. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and strategy;Ng;Ann Surg,1992

4. Efficacy and safety of Imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N Eng J Med,2002

5. DeMatteo R: ASCO 2007, abstract 10079.

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of neoadjuvant therapy for localized gastric gastrointestinal stromal tumors and the association with survival;Journal of Gastrointestinal Surgery;2024-09

2. Rectal Gastrointestinal Stromal Tumour: A Report of a Rare Case and Literature Review;Cureus;2024-08-27

3. Monitoring neoadjuvant treatment-induced surgical benefit in GIST patients using CT-based radiological criteria;Surgery Open Science;2024-08

4. Gastrointestinal Stromal Tumors: A Retrospective Study at a Tertiary Care Center in Saudi Arabia in the Last Decade;Cureus;2024-07-15

5. Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines;British Journal of Cancer;2024-06-05